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1. Introduction
   Amoebic liver abscess (ALA) is a fatal manifestation of the 
enteric protozoan Entamoeba histolytica (E. histolytica). Human 
and some non-human primates are the main reservoirs for 
this protozoan[1]. In order to simulate human ALA to better 
understand the underlying pathogenesis, mouse, rat and rabbit 
models have been tested, but only hamster (Mesocricetus 
auratus) and gerbil (Meriones unguiculatus) were reported 
to be susceptible to the trophozoites[2]. The experimental 
infection routes include direct inoculation of viable, virulence 
trophozoites into the liver, hepatic portal vein or peritoneal 
cavity of the animal[3]. ALA infected rodent usually deteriorates 
to moribund state in approximately a week, which is 
accompanied by increase malaise, liver tenderness, lethargy 
and reduce appetite. 
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Objective: To characterize the Entamoeba histolytica (E. histolytica) antigen(s) recognized by 
moribound amoebic liver abscess hamsters. 
Methods: Crude soluble antigen of E. histolytica was probed with sera of moribund hamsters 
in 1D- and 2D-Western blot analyses. The antigenic protein was then sent for tandem mass 
spectrometry analysis. The corresponding gene was cloned and expressed in Escherichia coli 
BL21-AI to produce the recombinant E. histolytica ADP-forming acetyl-CoA synthetase (EhACS) 
protein. A customised ELISA was developed to evaluate the sensitivity and specificity of the 
recombinant protein.
Results: A ~75 kDa protein band with a pI value of 5.91-6.5 was found to be antigenic; and not 
detected by sera of hamsters in the control group. Tandem mass spectrometry analysis revealed 
the protein to be the 77 kDa E. histolytica ADP-forming acetyl-CoA synthetase (EhACS). The 
customised ELISA results revealed 100% sensitivity and 100% specificity when tested against 
infected (n=31) and control group hamsters (n=5) serum samples, respectively. 
Conclusions: This finding suggested the significant role of EhACS as a biomarker for moribund 
hamsters with acute amoebic liver abscess (ALA) infection. It is deemed pertinent that future 
studies explore the potential roles of EhACS in better understanding the pathogenesis of ALA; and 
in the development of vaccine and diagnostic tests to control ALA in human populations.
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   In rodents, antibodies produced against pathogen could 
be detected as early as 5-7 d, post infection[4]. Hence, 
the antibodies produced during the acute stage may 
recognise potentially important biomarker(s) pertinent to the 
understanding of pathogenesis, vaccine development and 
diagnosis of ALA. To date, there was no report on the analysis of 
antibodies produced in either hamster or gerbil post-infected 
with virulent E. histolytica trophozoites.
   The objective of this study was to identify and characterize 
potential E. histolytica biomarker(s) recognised by sera of 
moribund ALA hamsters.
2. Materials and methods
2.1. HM-1:IMSS E. histolytica culture
   HM-1:IMSS E. histolytica trophozoites were axenically cultured 
in Diamond TYI-S-33 medium[5]. The trophozoites were 
continuously passed through the liver of hamsters to maintain 
their virulence.
2.2. Experimental ALA in hamster and serum collection
   The animal experimentation was conducted in accordance 
with the requirements of Universiti Sains Malaysia Animal 
Ethics Committee, PPSG/07(A)/044/(2008)(40). A maximum of 
three 8-10 week old male hamsters were housed in each 
polycarbonate cage with regular changes of clean woodchips 
beddings. The animals were provided with alternate 12 h 
lighting and 12 h darkness, as well as ad libitum food 
pellets and water. ALA was induced by inoculating each 
hamster with 1伊106 trophozoites in 0.2 mL phosphate 
buffered saline via the portal vein[6]. In approximately 
6-8 d post-inoculation, the hamster was euthanised with 
three-time overdose of sodium pentobarbital. Blood was 
immediately collected via cardiac puncture into a sterile 
micro-centrifuge tube and allowed to clot. Serum was 
separated, labelled as ‘hamster ALA serum’ and kept at -20 
°C until used. In the control group, each healthy animal 
was inoculated with 0.2 mL sterile phosphate buffer saline 
(PBS) without the trophozoites. The serum collected was 
labelled as ‘hamster control serum’ and kept at -20 °C until 
used. Twenty microlitres of each ALA serum sample were 
pooled into a microfuge tube, mixed and labelled as ‘pooled 
hamster ALA sera’. Similarly, ‘pooled hamster control sera’ 
were pooled from the control serum samples.
2.3. Preparation of crude soluble antigen (CSA) 
   Ten million E. histolytica trophozoites were mixed with 
500 µL complete Lysis-M buffer added with protease inhibitor 
cocktail (Roche, Germany) and 20 µL of 0.5 mol/L iodoacetamide 
(Sigma, USA). The mixture was sonicated (Branson, UK) at 10% 
amplitude for three cycles of 1 min sonication with 0.5 seconds 
pulse-on and 0.5 seconds pulse-off. The lysate was then 
centrifuged at 10 000 伊 g (9020 r/min) for 10 min at 4 °C to collect 
the CSA supernatant.
2.4. 1D-PAGE and Western blot analysis
   Twenty micrograms of CSA per well were separated by 9% 
sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and electro-blotted (Bio-Rad, USA) onto a 0.45 
µm-pore-size nitrocellulose membrane. The membrane was 
blocked for 1 h at room temperature with 5% skimmed milk. 
Subsequently, the membrane was cut into multiple strips 
and each strip was incubated with Tris-buffered saline (TBS) 
control, pooled hamster control sera, individual hamster ALA 
serum samples, or pooled hamster ALA sera at dilution of 1:50 
in TBS containing 0.1% Tween 20 (TBS-T) for 2 h at RT. After 
washing with TBS-T for 3伊5 min, the strips were incubated 
with monoclonal mouse anti-hamster IgG-HRP (Sigma, USA) 
at a dilution of 1: 4 000 in TBS for 1 h at RT. The signals were 
developed using enhanced chemiluminescence (ECL) blotting 
reagent (Roche Diagnostics, Germany) and captured using 
X-ray film.
2.5. 2D-PAGE and Western blot analysis 
   The proteins of E. histolytica CSA were first fractionated 
based on their isoelectric points (pI) using 3100 OFFGEL 
Fractionator (Agilent Technologies, Germany). ImmobilineTM 
Dry Strip (GE Healthcare, UK) with linear pH range 3-10 in 
a 12-well setup was used. The fractionation was performed 
according to the manual provided by the manufacturer. 
Twenty microlitres of a fractionated protein sample were 
mixed with 5 µL of 5X sample buffer without boiling, and 
subsequently separated by 9% SDS-PAGE. Western blot 
analysis was performed on the 12 protein fractions using 
pooled hamster ALA sera and pooled hamster control sera 
to identify the antigenic fraction(s). For confirmation of the 
antigenic fraction, the Western blot experiment was repeated 
on the fraction using individual hamster ALA serum samples.
2.6. Mass spectrometry analysis and protein identification
   The antigenic protein band was sent to the Australian 
Proteomic Service for tandem mass spectrometry (MS/MS) 
analysis. At the proteomic facility, the protein sample was 
digested with trypsin and the peptides were extracted and 
analysed by electro-spray ionisation mass spectrometry using 
the Ultimate 3000 nano high performance liquid chromatography 
system [Dionex] coupled to a 4000 Q TRAP mass spectrometer 
[Applied Biosystems]. The mass-spectrometry analysis was 
performed with two different gel slice samples to ensure 
reproducibility. According to peptides sequence BLAST via 
Mascot, E. histolytica acetyl-CoA synthetase (UniProt accession 
number: Q9NAT4) was identified.
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2.7. Cloning and expression of recombinant acetyl-CoA 
synthetase
   Genomic DNA was isolated from 3伊106 E. histolytica 
trophozoites using QIAamp DNA mini kit (QIAGEN GmbH, 
Germany). PCR primers targeting the amplification of E. 
histolytica acetyl-CoA synthetase (EhACS) gene from the 
genomic DNA were F-5’-GGA ATT CCA TAT GAT GCA ATT TGA 
GCC ACT and R-5’-CCG CTC GAG TTA TGG TTG GAT GAC GA. The 
PCR product (2 142 bp) was cloned into the pET-14b vector and 
confirmed via sequencing. Recombinant EhACS (rEhACS), was 
then propagated in Escherichia coli XL 1-blue and expressed in 
Escherichia coli BL21-AI. During expression, 1 mL of overnight 
starter culture was inoculated into 50 mL Luria-Bertani broth 
supplemented with 50 µg/mL ampicillin. At OD600 0.6-0.8, over-
expression of rEhACS protein was induced with 0.2% (w/v) 
L-arabinose at 32 °C, overnight. The recombinant protein was 
purified using HisPurTM Ni-NTA Resin (Fisher Scientific, USA), 
according to the manufacturer’s protocol, and the concentration 
was estimated using the Bradford method.
2.8. Evaluation of rEhACS via indirect ELISA
   The rEhACS identified as a potential biomarker in hamster 
experimentation was evaluated using hamster ALA serum 
samples in an indirect-ELISA format. The customised rEhACS-
ELISA was optimized and performed based on modifications of 
the method described by Reen[7]. Each well of the flat-bottom 
microtiter plate (NUNC, Denmark) was coated with 100 µL of 
25 µg/µL of the recombinant protein in 0.1 mol/L carbonate 
buffer, pH 9.6, overnight at 4 °C in a humid box. Each well was 
then blocked with 200 µL blocking reagent (Roche, Germany) 
for 1 h. Then, 100 µL of each hamster serum sample, followed 
by 100 µL of monoclonal mouse anti-hamster IgG-HRP (Sigma, 
USA) were incubated in each well for 1 h at serum dilutions of 
1:100 and 1:1 000 in PBS, respectively. Each cycle of washing (3伊
5 min) was performed using 200 µL per well of phosphate-buffer 
saline (PBS) containing 0.05% Tween 20. After a final incubation 
with 100 µL TMB substrate per well for 15 min in the dark, 100 µL 
of 1 N H2SO4 was added as the stop solution. The absorbances 
were read at 450 nm using a Multiskan FC Microplate Reader 
(Fisher Scientific, USA). The cut-off value for the indirect ELISA 
was then determined based on the mean optical density (OD) 
readings plus 2 standard deviations (SD) obtained for the five 
hamster control serum samples.
3. Results
3.1. 1D-Western blot analysis of CSA probed with hamster serum 
samples
   The antigenic profile of CSA probed with the hamster ALA 
serum samples revealed 5 antigenic bands, i.e. ~100 kDa, 
~75 kDa, ~65 kDa, ~50 kDa and ~45 kDa, which did not react 
with the controls. Interestingly, only the ~75 kDa protein band 
was detected by all the hamster ALA serum samples (Figure 1).
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Figure 1. Western blot analysis of CSA probed with hamster serum samples 
(Representive data). 
MP+: Pooled hamster ALA sera; MP-: Pooled hamster healthy sera; M1-M6 
represent individual hamster ALA serum samples.
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Figure 2. Western blot analysis of fractionated CSA probed with hamster pooled control and ALA serum samples. 
*: Position of ~75 kDa protein band; M+: Pooled hamster ALA sera; M-: Pooled hamster healthy sera.
*
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3.2. 2D protein separation and identification
   CSA was fractionated into 12 fractions according to the pI 
values of its proteins. Western blot analysis of the fractions 
revealed that the expected ~75 kDa protein was located mostly 
in Fraction 6 with a pI range of 5.91-6.5 (Figure 2). Further 
Western blot analysis on this protein fraction indicated that the 
~75 kDa protein was recognized by all the individual hamster 
ALA serum samples (Figure 3). The targeted protein band was 
excised from SDS-PAGE gel and sent for MS/MS analysis. Mass 
spectrometric analysis identified the ~75 kDa antigenic protein 
as: tr|C4LUV9|acetyl-CoA synthetase, putative Tax_Id=5759 [E. 
histolytica]. The protein and peptide scores were 294 and 1 456 
respectively, with sequence coverage of 44%. In the peptide 
report, there were 7 of 48 peptides which were above the cut-off 
ion score of 60 which indicated identity or extensive homology 
(P<0.05).
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Figure 3. 2D-Western blot analysis of CSA probed with individual hamster 
ALA serum samples. 
*: Position of the ~75kDa protein band; M1+ to M5+: Individual hamster 
ALA serum samples; MP+: Pooled hamster ALA sera; M-: Pooled hamster 
control sera.
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3.3. Examination rEhACS antigenicity via ELISA
   In the customized rEhACS-ELISA, a cut-off value of 0.1 573 
was determined based on mean OD+2SD of the five hamster 
control serum samples. The ELISA revealed 100% sensitivity 
and specificity when tested with serum samples from 
moribund hamster with ALA (n=31) and the control group (n=5), 
respectively (Figure 4).
Figure 4. OD450 distribution of hamster ALA and control serum samples in 
rEhACS-ELISA.
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4. Discussion
   Virulent strain of HM-1:IMSS of E. histolytica was maintained 
by routinely passing the trophozoites through hamster livers 
twice a month[6]. In this study, serum samples obtained from the 
euthanized animals were found to possess sufficient antibodies 
for immunoblot analysis. In the Western blot analyses, all the 
ALA hamster sera, but not the healthy control sera, were found 
to recognise the 77 kDa E. histolytica ADP-forming ACS. This 
is therefore a potential diagnostic marker during the acute 
and terminal stage of the infection. The detectable antibody 
level produced during this relatively short period of 7 d was 
in accordance with a previous report that revealed rodent 
antibodies were generally first detected between 5-7 d post-
infection[4]. 
   In experimentally induced hamster ALA, there was massive 
death of trophozoites during the first few hours post-infection[6]. 
It is highly probable that E. histolytica antigens, including 
EhACS, released from these dead amoebas triggered the host 
humoral responses during this early stage of infection. It was 
also pointed out that the 12 h post-infection period was the 
critical stage for successful invasion by the amoebas into the 
hamster liver, where the lowest number of trophozoites was 
observed in the infected liver[6]. Possibly the live amoebas 
continued to secrete or excrete EhACS that boosted the 
production of antibody, or antibody production was due to 
release of the highly immunogenic antigen during subsequent 
death of trophozoites.
   In mitochondrial organisms, acetyl-CoA is the fuel for 
tricarboxylic acid cycle but this pathway is absent from the 
amitochondriate E. histolytica. The amoeba ADP-forming 
converts acetyl-CoA to acetate by hydrolysis to generate ATP 
from ADP and Pi[8]. However, it does not appear to synthesise 
ATP from AMP and Ppi[9]. Interestingly, it is also involved in 
degradation of amino acids by accepting propionyl-CoA as a 
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substrate to generate ATP[8,10]. Although the functions of EhACS 
in E. histolytica metabolism are relatively well reported, its 
potential roles in pathogenesis, vaccine and diagnosis are 
basically unexplored[11-13]. 
   In conclusion, this study has successfully identified EhACS as 
a biomarker for ALA in moribund hamsters. The potential role(s) 
of EhACS in elucidating pathogenesis, developing vaccine and 
improving diagnosis of human amoebiasis should be further 
studied.
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Comments 
Background
   ALA is a fatal manifestation of E. histolytica. To better 
understand the pathogenesis of human ALA, hamster 
(Mesocricetus auratus) has been used to maintain the 
virulence of E. histolytica in liver of hamster. This study 
attempted to identify and characterize potential biomarker(s) 
of E. histolytica recognized by antibodies of hamsters with 
acute ALA.
  
Research frontiers
   This is the first study that utilized a 5-7 d post-infected 
hamster sera in Western blotting to reveal E. histolytica 
acetyl-CoA synthetase as a potentially important biomarker 
in acute ALA infection.
Related reports
   The E. histolytica acetyl-CoA synthetase recombinant 
protein was subsequently expressed and utilized in an 
indirect ELISA format to show that it was highly specific and 
sensitive in the detection of hamster antibodies during acute 
stage of ALA infection. There are no other reports and this is 
a new finding.
Innovations and breakthroughs
   The innovative aspect of this paper is the utilization of 
5-7 d sera obtained from hamsters with acute ALA to perform 
Western blotting to identify the biomarker. In comparison, 
other studies normally focused on the infected liver. 
Applications
   The potential roles of EhACS in elucidating pathogenesis, 
developing vaccine and improving diagnosis of human 
amoebiasis should be further studied. In addition, it 
would be interesting to ascertain the potential of rEhACS in 
determining antibodies from human with ALA. 
Peer review
   This is a well-researched and clearly presented 
manuscript that will be useful to both fundamental and 
applied scientists who research on E. histolytica, the 
parasitic protozoan that causes high morbidity and mortality 
in developing countries endemic for the infection.
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